Oct 28, 2022 1:20pm EDT SeaStar Medical Completes Business Combination with LMF Acquisition Opportunities
Oct 18, 2022 6:00pm EDT LMF Acquisition Opportunities, Inc. Stockholders Approve Previously Announced Business Combination with SeaStar Medical, Inc.
Sep 28, 2022 5:00pm EDT LMF Acquisition Opportunities and SeaStar Medical Announce Effectiveness of Registration Statement and Special Meeting of Stockholders to be Held October 18, 2022 to Approve Business Combination
Sep 19, 2022 8:30am EDT SeaStar Medical Appoints Dr. Sai Prasad Iyer, Ph.D as VP, Medical Affairs and Clinical Development
Aug 01, 2022 8:00am EDT SeaStar Medical Reports First Successful Treatment of Pediatric Patient with Hemophagocytic Lymphohistiocytosis (HLH) and Multi-Organ Failure with its SCD
Jul 29, 2022 6:00pm EDT LMF Acquisition Opportunities, Inc. Announces Extension of Deadline to Complete Business Combination
Jul 20, 2022 8:00am EDT SeaStar Medical Submits Humanitarian Device Exemption Application to FDA for Use of Selective Cytopheretic Device in Children with Acute Kidney Injury
Jun 07, 2022 8:30am EDT SeaStar Medical Announces Publication of Clinical Trial Results Demonstrating its SCD Significantly Lowered Mortality Rates among Critically Ill ICU COVID-19 Patients by Safely and Effectively Stopping Inflammation Causing Cytokine Storms
May 03, 2022 8:00am EDT SeaStar Medical Granted FDA Breakthrough Device Designation for a Novel Immunomodulatory Therapy for Acute Kidney Injury Patients
